Senescent Gum Fibroblasts Drive Periodontitis via Complement-Neutrophil Cascade
A CD81+ senescent fibroblast subpopulation fuels gum disease by secreting inflammatory factors and recruiting neutrophils through the C3/C3aR1 axis.
Summary
Researchers identified a distinct CD81+ senescent-like fibroblast population in periodontitis that accumulates in gum tissue and drives chronic inflammation. These cells secrete SASP factors like IL-6 and activate neutrophils via complement protein C3 signaling through C3aR1. Using human gingival samples, mouse ligature-induced periodontitis models, and single-cell RNA sequencing, the team showed senescent cells peak at day 7 post-ligation. Targeting these cells with the senolytic drug Navitoclax or metformin reduced inflammation and alveolar bone loss, suggesting cellular senescence is a viable therapeutic target in periodontitis.
Detailed Summary
Periodontitis affects over 11% of the global population and worsens with age, yet the cellular mechanisms linking chronic bacterial infection to irreversible tissue destruction remain incompletely understood. This study investigates whether cellular senescence—a state of permanent cell-cycle arrest accompanied by pro-inflammatory secretion—plays a causal role in periodontitis progression and identifies the key cell types and molecular pathways involved.
Using clinical gingival biopsies from periodontitis patients and healthy controls, the researchers confirmed elevated senescence markers including SA-β-galactosidase activity, p16, p21, and H3K9me3 in diseased tissue, predominantly in the lamina propria. A ligature-induced periodontitis (LIP) mouse model showed p16 expression peaked at day 7 post-ligation. Bulk RNA sequencing of LIP gingiva revealed upregulation of senescence-related genes, SASP factors, and activation of PI3K-AKT, MAPK, and NF-κB pathways, alongside mitochondrial dysfunction signatures.
Single-cell RNA sequencing of human periodontitis gingival tissue identified gingival fibroblasts as the predominant senescent cell population. Within this population, a distinct subcluster marked by high CD81 expression displayed hallmarks of senescence: ROS accumulation, elevated p16/p21, enrichment of senescence gene sets, and robust SASP secretion including IL-6, IL-8, and IL-1α. CD81+ fibroblasts showed heightened pro-inflammatory metabolic activity and were significantly expanded in periodontitis versus healthy gingiva.
Critically, the study uncovered a paracrine mechanism by which CD81+ senescent fibroblasts recruit and activate neutrophils. These fibroblasts highly expressed complement component C3, and conditioned medium from senescent fibroblasts promoted neutrophil migration and activation. Blocking C3 or its receptor C3aR1 on neutrophils attenuated this effect, establishing the C3/C3aR1 axis as a key bridge between fibroblast senescence and innate immune amplification. This neutrophil recruitment loop likely sustains chronic inflammation and accelerates alveolar bone resorption.
Therapeutically, treatment with the senolytic Navitoclax (ABT-263) selectively cleared senescent cells in the LIP model, reducing inflammatory cytokine levels and attenuating bone loss. Metformin, a widely used diabetes drug with known anti-senescence properties, similarly reduced senescence markers, SASP secretion, and bone destruction. These findings position CD81 as a potential biomarker for senescent gingival fibroblasts and suggest that targeting the CD81+ fibroblast–neutrophil axis—particularly via senolytic or anti-senescence strategies—represents a novel therapeutic approach for periodontitis.
Key Findings
- CD81+ gingival fibroblasts are the dominant senescent cell population in human periodontitis gingival tissue.
- Senescent fibroblasts recruit and activate neutrophils via secreted complement C3 signaling through C3aR1.
- Senescence markers p16, p21, and SA-β-gal are significantly elevated in periodontitis gingiva versus healthy controls.
- Navitoclax (senolytic) and metformin both reduced senescence, inflammation, and alveolar bone loss in mouse models.
- Bulk RNA-seq confirmed activation of SASP, PI3K-AKT, MAPK, and NF-κB pathways in periodontitis gingiva.
Methodology
The study combined human gingival biopsies, a mouse ligature-induced periodontitis model, bulk RNA-seq, and multiple scRNA-seq datasets to characterize senescent cell populations. In vitro experiments used conditioned media from senescent fibroblasts to assess neutrophil recruitment, with C3/C3aR1 pathway blockade experiments. Therapeutic interventions included Navitoclax and metformin in the LIP mouse model.
Study Limitations
Mouse ligature models do not fully replicate the chronic polymicrobial nature of human periodontitis. The study is primarily observational regarding human tissue, with mechanistic experiments conducted in vitro and in mice. Long-term safety and efficacy of senolytic treatment in the oral cavity require further clinical investigation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.